|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-2-6
|
|
pubmed:abstractText |
It has been reported that the combination of gemcitabine (LY188011; GEM) and cisplatin (CDDP) in a 4-week schedule showed a high response rate for patients with non-small-cell lung cancer (NSCLC), but GEM could not be administered on day 15 because of increased myelosuppression in many patients. The present study was performed to evaluate the efficacy and safety of GEM and CDDP in a 3-week schedule.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1341-9625
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
284-90
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11828947-Adult,
pubmed-meshheading:11828947-Aged,
pubmed-meshheading:11828947-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11828947-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11828947-Cisplatin,
pubmed-meshheading:11828947-Deoxycytidine,
pubmed-meshheading:11828947-Dose-Response Relationship, Drug,
pubmed-meshheading:11828947-Drug Administration Schedule,
pubmed-meshheading:11828947-Female,
pubmed-meshheading:11828947-Hematologic Diseases,
pubmed-meshheading:11828947-Humans,
pubmed-meshheading:11828947-Incidence,
pubmed-meshheading:11828947-Japan,
pubmed-meshheading:11828947-Lung Neoplasms,
pubmed-meshheading:11828947-Male,
pubmed-meshheading:11828947-Maximum Tolerated Dose,
pubmed-meshheading:11828947-Middle Aged,
pubmed-meshheading:11828947-Neoplasm Staging,
pubmed-meshheading:11828947-Pilot Projects,
pubmed-meshheading:11828947-Survival Rate,
pubmed-meshheading:11828947-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
A study of the combination of gemcitabine hydrochloride (LY188011) and cisplatin in non-small-cell lung cancer: 3-week schedule.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Yokohama Municipal Citizen's Hospital, 56 Okazawacho, Hodogaya-ku, Yokohama 240-8555, Japan. kunikane@courante.plala.or.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
